1. Home
  2. UTHR vs FLEX Comparison

UTHR vs FLEX Comparison

Compare UTHR & FLEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTHR
  • FLEX
  • Stock Information
  • Founded
  • UTHR 1996
  • FLEX 1990
  • Country
  • UTHR United States
  • FLEX United States
  • Employees
  • UTHR N/A
  • FLEX N/A
  • Industry
  • UTHR Biotechnology: Pharmaceutical Preparations
  • FLEX Electrical Products
  • Sector
  • UTHR Health Care
  • FLEX Technology
  • Exchange
  • UTHR Nasdaq
  • FLEX Nasdaq
  • Market Cap
  • UTHR 14.4B
  • FLEX 12.9B
  • IPO Year
  • UTHR 1999
  • FLEX 1994
  • Fundamental
  • Price
  • UTHR $306.97
  • FLEX $33.18
  • Analyst Decision
  • UTHR Buy
  • FLEX Strong Buy
  • Analyst Count
  • UTHR 12
  • FLEX 6
  • Target Price
  • UTHR $388.25
  • FLEX $46.17
  • AVG Volume (30 Days)
  • UTHR 492.5K
  • FLEX 3.7M
  • Earning Date
  • UTHR 04-30-2025
  • FLEX 04-30-2025
  • Dividend Yield
  • UTHR N/A
  • FLEX N/A
  • EPS Growth
  • UTHR 24.38
  • FLEX 46.11
  • EPS
  • UTHR 24.64
  • FLEX 2.48
  • Revenue
  • UTHR $2,877,400,000.00
  • FLEX $25,584,000,000.00
  • Revenue This Year
  • UTHR $11.70
  • FLEX N/A
  • Revenue Next Year
  • UTHR $6.50
  • FLEX $2.58
  • P/E Ratio
  • UTHR $12.40
  • FLEX $13.35
  • Revenue Growth
  • UTHR 23.63
  • FLEX N/A
  • 52 Week Low
  • UTHR $221.53
  • FLEX $25.27
  • 52 Week High
  • UTHR $417.82
  • FLEX $45.10
  • Technical
  • Relative Strength Index (RSI)
  • UTHR 39.02
  • FLEX 35.81
  • Support Level
  • UTHR $308.43
  • FLEX $35.26
  • Resistance Level
  • UTHR $318.40
  • FLEX $37.76
  • Average True Range (ATR)
  • UTHR 9.26
  • FLEX 1.23
  • MACD
  • UTHR 1.20
  • FLEX 0.11
  • Stochastic Oscillator
  • UTHR 29.88
  • FLEX 8.22

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

About FLEX Flex Ltd.

Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.

Share on Social Networks: